Corticosteroids Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| CAGR | 4.30 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Corticosteroids Market Analysis
The corticosteroid market is expected to witness a CAGR of 4.3% during the forecast period (2022-2027).
The COVID-19 pandemic has had a substantial influence on worldwide healthcare systems, as well as the market for corticosteroids. Early in the pandemic, epidemiological data showed that people with Chronic obstructive pulmonary disease (COPD) and asthma had a decreased rate of COVID-19 infection, leading to the suggestion that inhaled corticosteroids would help. In addition, in September 2020, the World Health Organization collaborated with investigators from seven corticosteroid trials to conduct a prospective meta-analysis of randomized trials for corticosteroid therapy for COVID-19 (PMA) to quickly provide additional evidence to complement the RECOVERY data and inform guidance development, according to a World Health Organization report due in September 2020. Moreover, according to the article published in BMC Infectious Disease in May 2021, in hospitalized hypoxic COVID-19 patients, methylprednisolone demonstrated better results compared to dexamethasone. As a result, the increased usage of corticosteroids in the treatment of COVID-19 patients demonstrates COVID-19's significant impact on the market.
The major factors accounting for the growth of the corticosteroid market are increasing the incidence of chronic diseases, the growing geriatric population, and surging investment in research and development. According to the United Nations report 2020, the estimated human population is expected to increase from 7.2 billion today to 8.2 billion by 2025. This, in turn, raises the global burden of chronic diseases to 57 percent by the end of 2020. According to the Centers for Disease Control and Prevention 2020 report, in the United States, approximately 25 million Americans have asthma. This equals to about 1 in 13 Americans, including 8% of adults and 7% of children. About 20 million United States adults aged 18 years and over have asthma. Corticosteroids are majorly used in the treatment of asthma, and the rising prevalence of it boosts the market growth over the forecast period.
Furthermore, according to the World Ageing 2020 report, in 2020, there were around 727 million people aged 65 years or more in the world. The number of older persons is projected to double to 1.5 billion in 2050. the geriatric population is more prone to chronic diseases which require corticosteroid therapy for various diseases that will help grow the market in the years to come.
Hence, this uninterrupted incidence and prevalence of chronic diseases lead to the growth of the Corticosteroids market during the forecast period. However, the risk factors associated with the prolonged use of corticosteroids hampers the growth of the market to some extent.
Corticosteroids Market Trends
This section covers the major market trends shaping the Corticosteroids Market according to our research experts:
Topical Steroids segment by Route of Administration Dominates the Market During the Forecast Period
Topical corticosteroids are a type of steroid medicine applied directly to the skin to reduce inflammation and irritation. Topical corticosteroids are available in several different forms, including creams, lotions, and gels.
Topical steroids are used in treating the skin conditions such as rash, dermatitis, itching, eczema, and psoriasis, and this segment is expected to dominate the market due to the continuous growth of the geriatric population with rising skin diseases around the world and the extended storage capacity of the topical corticosteroids.
As aging results in the decline of the normal functioning of organ systems, including skin, the geriatric population is highly prone to skin diseases. According to the data from World Population Prospects 2022, the share of the global population aged 65 years or above is projected to rise from 10 per cent in 2022 to 16 per cent in 2050. By 2050, the number of persons aged 65 years or over worldwide is projected to be more than twice the number of children under age 5 and about the same as the number of children under age 12. In terms of convenience, the geriatric population with skin diseases prefers to use topical steroids.
All these factors together support that Topical steroids dominate the corticosteroids market.
North America Dominates the Market and the Same is Expected Over the Forecast Period.
North America is expected to dominate the overall market throughout the forecast period, which is attributed to the developed economy, increasing health care expenditure, increasing incidence of lifestyle-related diseases, and high adoption of technologically advanced products in the region.
According to the Globocan 2020 report, an estimated 2,281,658 new cancer cases were diagnosed in the United States in 2020. In 2020, The most common cancers were breast (253,465), lung (227,875), prostate (209,512), and colon (101,809) in the United States. Furthermore, According to the Centers for Disease Control and Prevention 2020 report, in the United States, approximately 25 million Americans have asthma. This equals to about 1 in 13 Americans, including 8% of adults and 7% of children. About 20 million United States adults aged 18 years and over have asthma. Also, according to the Asthma and Allergy Foundation of America (AAFA), in 2021, roughly 1 in 13 Americans had asthma, which is about 25 million people. As per the same source, about 5 million American children have asthma which strongly supports North America to dominate the market during the forecast period.
Furthermore, in the United States, asthma is more common in adult women than in adult men. According to the Centers for Disease Control and Prevention 2020 report, in the United States, approximately 25 million Americans have asthma. This equals to about 1 in 13 Americans, including 8% of adults and 7% of children. About 20 million United States adults age 18 and over have asthma. Similarly, asthma is a major public health concern in Canada. As a lifelong respiratory illness, asthma affects the work productivity, quality of life, mental health, and psychological well-being of the Canadian population.
Thus, the increasing prevalence of asthma is expected to raise the demand for corticosteroids, thereby boosting the market in the region.
Corticosteroids Industry Overview
The corticosteroid market is moderately competitive and consists of several major players. With the increasing consolidations of various organizations in the healthcare sector, it is expected to generate competitive rivalry among the key players in the future. Some of the major players in the market are Pfizer Inc., Novartis, AstraZeneca, GSK, Cipla Inc., Merck, etc.,
Corticosteroids Market Leaders
-
Pfizer Inc.
-
Novartis
-
GSK
-
Merck
-
AstraZeneca
*Disclaimer: Major Players sorted in no particular order
Corticosteroids Market News
- In April 2022, Lilly's lebrikizumab combined with topical corticosteroids showed significant improvements in disease severity for atopic dermatitis
- In August 2022, the first patient was been dosed in a pilot study evaluating vamorolone as a potential treatment for Becker muscular dystrophy (BMD). The steroid medication has been under development by ReveraGen BioPharma as a possible therapy for other types of muscular dystrophy.
Corticosteroids Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Growing Geriatric Population and Increasing Incidence of Chronic Diseases
- 4.2.2 Surging investment in Research and Development
-
4.3 Market Restraints
- 4.3.1 Pricing Pressure on the Companies by the Government
- 4.3.2 Risk factors associated with Corticosteriods on Prolonged use
-
4.4 Porter's Five Forces Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD million)
-
5.1 By Product
- 5.1.1 Glucocorticoids
- 5.1.2 Mineralocorticoids
-
5.2 By Route of administration
- 5.2.1 Topical steroids
- 5.2.2 Inhaled steroids
- 5.2.3 Oral forms
- 5.2.4 Systemic forms
- 5.2.5 Others
-
5.3 By Application
- 5.3.1 Rheumatology indications
- 5.3.2 Skin allergies
- 5.3.3 Endocrinology
- 5.3.4 Gastroenterology
- 5.3.5 Acute respiratory diseases
- 5.3.6 Others
-
5.4 Geography
- 5.4.1 North America
- 5.4.1.1 United States
- 5.4.1.2 Canada
- 5.4.1.3 Mexico
- 5.4.2 Europe
- 5.4.2.1 Germany
- 5.4.2.2 United Kingdom
- 5.4.2.3 France
- 5.4.2.4 Italy
- 5.4.2.5 Spain
- 5.4.2.6 Rest of Europe
- 5.4.3 Asia-Pacific
- 5.4.3.1 China
- 5.4.3.2 Japan
- 5.4.3.3 India
- 5.4.3.4 Australia
- 5.4.3.5 South Korea
- 5.4.3.6 Rest of Asia-Pacific
- 5.4.4 Middle-East and Africa
- 5.4.4.1 GCC
- 5.4.4.2 South Africa
- 5.4.4.3 Rest of Middle-East and Africa
- 5.4.5 South America
- 5.4.5.1 Brazil
- 5.4.5.2 Argentina
- 5.4.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Pfizer Inc.
- 6.1.2 Novartis AG
- 6.1.3 Sanofi S.A.
- 6.1.4 GlaxoSmithKline plc
- 6.1.5 Cipla Inc.
- 6.1.6 Johnson & Johnson Services, Inc.
- 6.1.7 AstraZeneca plc
- 6.1.8 Merck & Co., Inc.,
- 6.1.9 Sumitomo Corporation
- 6.1.10 Leo Pharma
- 6.1.11 Bayer Pharmaceutical
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityCorticosteroids Industry Segmentation
Corticosteroids are the steroid hormones that are either produced by the body (Systemic corticosteroids) or man-made (Synthetic corticosteroids). When the adrenal cortex ceases the production of required corticosteroids, synthetic corticosteroids are given to the patients. They are often used as part of treatment for different diseases like asthma, various skin allergies, and arthritis, among others. The corticosteroids market is segmented by Product type (Glucocorticoids, Mineralocorticoids), Route of Administration (Topical steroids, Inhaled steroids, Oral forms, Systemic forms), Application (Rheumatology indications, Skin allergies, Endocrinology, Gastroenterology, Acute respiratory diseases, Others), and Geography (North America, Europe, Asia-Pacific, Middle East & Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.
| By Product | Glucocorticoids | |
| Mineralocorticoids | ||
| By Route of administration | Topical steroids | |
| Inhaled steroids | ||
| Oral forms | ||
| Systemic forms | ||
| Others | ||
| By Application | Rheumatology indications | |
| Skin allergies | ||
| Endocrinology | ||
| Gastroenterology | ||
| Acute respiratory diseases | ||
| Others | ||
| Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Geography | Europe | Germany |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| Geography | Asia-Pacific | China |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| Rest of Asia-Pacific | ||
| Geography | Middle-East and Africa | GCC |
| South Africa | ||
| Rest of Middle-East and Africa | ||
| Geography | South America | Brazil |
| Argentina | ||
| Rest of South America |
Corticosteroids Market Research FAQs
What is the current Global Corticosteroids Market size?
The Global Corticosteroids Market is projected to register a CAGR of 4.30% during the forecast period (2024-2029)
Who are the key players in Global Corticosteroids Market?
Pfizer Inc. , Novartis, GSK, Merck and AstraZeneca are the major companies operating in the Global Corticosteroids Market.
Which is the fastest growing region in Global Corticosteroids Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Global Corticosteroids Market?
In 2024, the North America accounts for the largest market share in Global Corticosteroids Market.
What years does this Global Corticosteroids Market cover?
The report covers the Global Corticosteroids Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Corticosteroids Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Corticosteroids Industry Report
Statistics for the 2024 Corticosteroids market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Corticosteroids analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
